Global Research Antibodies & Reagents Market Report

Description

List of Tables

The global demand for Research Antibodies & Reagents Market is presumed to reach the market size of nearly USD 29.98 BN by 2030 from USD 14.01 BN in 2022 with a CAGR of 8.82% under the study period 2023 - 2030.

Research antibodies & reagents are generally utilized to detect an unconjugated primary antibody which is further used to target antigen. Research antibodies & reagent products assist in detecting, measuring and purifying proteins or biomolecules in different applications such as flow cytometry, ELISA, immunohistochemistry and more.

MARKET DYNAMICS:

The rise in demand for high-quality antibodies for research reproducibility is one of the major factors driving the growth of the research antibodies and reagents market. Moreover, rising investment in medical and health R&D is expected to fuel growth in the research antibodies and reagents market. The growing applications of biosciences and biotechnology in healthcare and pharmaceutical fields are driving demand. Furthermore, increased investment in the life sciences industry is driving up the need for research antibodies and reagents. Additionally, the increase in industry-academia collaboration and rising stem cell and neurobiology research field further influences the research antibodies and reagents market. However, the high cost and time related to identifying and developing potential antibodies are expected to hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of research antibodies & reagents. The growth and trends of research antibodies & reagents industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the research antibodies & reagents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Reagent
Media & Sera
Stains & Dyes
Fixatives
Buffers
Solvents
Enzymes
Probes
Other Reagents
Antibodies

By Type

Primary Antibodies
Secondary Antibodies

By Form

Monoclonal
Polyclonal
Recombinant

By Source

Mice
Rabbits
Other Sources

By Research Area

Oncology
Infectious Diseases
Immunology
Neurobiology
Stem Cells
Other Research Areas

By Technology

Western Blotting
Flow Cytometry
Enzyme-Linked Immunosorbent Assay (Elisa)
Immunohistochemistry
Immunofluorescence
Immunoprecipitation
Other Technologies

By Application

Proteomics
Drug Development
Genomics

By End User

Pharmaceutical & Biotechnologies Industries
Academic & Research Institutions
Contract Research Organizations

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Research Antibodies & Reagents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the research antibodies & reagents market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Abcam plc (UK), Becton, Dickinson, and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218746

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . RESEARCH ANTIBODIES & REAGENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Form
- 3.7.4 Market Attractiveness Analysis By Source
- 3.7.5 Market Attractiveness Analysis By Research Area
- 3.7.6 Market Attractiveness Analysis By Technology
- 3.7.7 Market Attractiveness Analysis By Application
- 3.7.8 Market Attractiveness Analysis By End User
- 3.7.9 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SALES BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Sales Data
6.3 Analysis by Product
6.4 Reagent Historic and Forecast Sales by Regions
6.5 Media & Sera Historic and Forecast Sales by Regions
6.6 Stains & Dyes Historic and Forecast Sales by Regions
6.7 Fixatives Historic and Forecast Sales by Regions
6.8 Buffers Historic and Forecast Sales by Regions
6.9 Solvents Historic and Forecast Sales by Regions
6.10. Enzymes Historic and Forecast Sales by Regions
6.11 Probes Historic and Forecast Sales by Regions
6.12 Other Reagents Historic and Forecast Sales by Regions
6.13 Antibodies Historic and Forecast Sales by Regions

7 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TYPE

7.1 Overview by Type
7.2 Historical and Forecast Sales Data
7.3 Analysis by Type
7.4 Primary Antibodies Historic and Forecast Sales by Regions
7.5 Secondary Antibodies Historic and Forecast Sales by Regions

8 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY FORM

8.1 Overview by Form
8.2 Historical and Forecast Sales Data
8.3 Analysis by Form
8.4 Monoclonal Historic and Forecast Sales by Regions
8.5 Polyclonal Historic and Forecast Sales by Regions
8.6 Recombinant Historic and Forecast Sales by Regions

9 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY SOURCE

9.1 Overview by Source
9.2 Historical and Forecast Sales Data
9.3 Analysis by Source
9.4 Mice Historic and Forecast Sales by Regions
9.5 Rabbits Historic and Forecast Sales by Regions
9.6 Other Sources Historic and Forecast Sales by Regions

10 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY RESEARCH AREA

10.1 Overview by Research Area
10.2 Historical and Forecast Sales Data
10.3 Analysis by Research Area
10.4 Oncology Historic and Forecast Sales by Regions
10.5 Infectious Diseases Historic and Forecast Sales by Regions
10.6 Immunology Historic and Forecast Sales by Regions
10.7 Neurobiology Historic and Forecast Sales by Regions
10.8 Stem Cells Historic and Forecast Sales by Regions
10.9 Other Research Areas Historic and Forecast Sales by Regions

11 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY TECHNOLOGY

11.1 Overview by Technology
11.2 Historical and Forecast Sales Data
11.3 Analysis by Technology
11.4 Western Blotting Historic and Forecast Sales by Regions
11.5 Flow Cytometry Historic and Forecast Sales by Regions
11.6 Enzyme-linked Immunosorbent Assay (ELISA) Historic and Forecast Sales by Regions
11.7 Immunohistochemistry Historic and Forecast Sales by Regions
11.8 Immunofluorescence Historic and Forecast Sales by Regions
11.9 Immunoprecipitation Historic and Forecast Sales by Regions
11.1 Other Technologies Historic and Forecast Sales by Regions

12 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY APPLICATION

12.1 Overview by Application
12.2 Historical and Forecast Sales Data
12.3 Analysis by Application
12.4 Proteomics Historic and Forecast Sales by Regions
12.5 Drug Development Historic and Forecast Sales by Regions
12.6 Genomics Historic and Forecast Sales by Regions

13 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY END USER

13.1 Overview by End User
13.2 Historical and Forecast Sales Data
13.3 Analysis by End User
13.4 Pharmaceutical & Biotechnologies Industries Historic and Forecast Sales by Regions
13.5 Academic & Research Institutions Historic and Forecast Sales by Regions
13.6 Contract Research Organizations Historic and Forecast Sales by Regions

14 . GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET ANALYSIS BY GEOGRAPHY

14.1. Regional Outlook
14.2. Introduction
14.3. North America Sales Analysis
- 14.3.1. Overview, Historic and Forecast Data Sales Analysis
- 14.3.2. North America By Segment Sales Analysis
- 14.3.3. North America By Country Sales Analysis
- 14.3.4. United State Sales Analysis
- 14.3.5. Canada Sales Analysis
- 14.3.6. Mexico Sales Analysis
14.4. Europe Sales Analysis
- 14.4.1. Overview, Historic and Forecast Data Sales Analysis
- 14.4.2. Europe by Segment Sales Analysis
- 14.4.3. Europe by Country Sales Analysis
- 14.4.4. United Kingdom Sales Analysis
- 14.4.5. France Sales Analysis
- 14.4.6. Germany Sales Analysis
- 14.4.7. Italy Sales Analysis
- 14.4.8. Russia Sales Analysis
- 14.4.9. Rest Of Europe Sales Analysis
14.5. Asia Pacific Sales Analysis
- 14.5.1. Overview, Historic and Forecast Data Sales Analysis
- 14.5.2. Asia Pacific by Segment Sales Analysis
- 14.5.3. Asia Pacific by Country Sales Analysis
- 14.5.4. China Sales Analysis
- 14.5.5. India Sales Analysis
- 14.5.6. Japan Sales Analysis
- 14.5.7. South Korea Sales Analysis
- 14.5.8. Australia Sales Analysis
- 14.5.9. Rest Of Asia Pacific Sales Analysis
14.6. Latin America Sales Analysis
- 14.6.1. Overview, Historic and Forecast Data Sales Analysis
- 14.6.2. Latin America by Segment Sales Analysis
- 14.6.3. Latin America by Country Sales Analysis
- 14.6.4. Brazil Sales Analysis
- 14.6.5. Argentina Sales Analysis
- 14.6.6. Peru Sales Analysis
- 14.6.7. Chile Sales Analysis
- 14.6.8. Rest of Latin America Sales Analysis
14.7. Middle East & Africa Sales Analysis
- 14.7.1. Overview, Historic and Forecast Data Sales Analysis
- 14.7.2. Middle East & Africa by Segment Sales Analysis
- 14.7.3. Middle East & Africa by Country Sales Analysis
- 14.7.4. Saudi Arabia Sales Analysis
- 14.7.5. UAE Sales Analysis
- 14.7.6. Israel Sales Analysis
- 14.7.7. South Africa Sales Analysis
- 14.7.8. Rest Of Middle East And Africa Sales Analysis

15 . COMPETITIVE LANDSCAPE OF THE RESEARCH ANTIBODIES & REAGENTS COMPANIES

15.1. Research Antibodies & Reagents Market Competition
15.2. Partnership/Collaboration/Agreement
15.3. Merger And Acquisitions
15.4. New Product Launch
15.5. Other Developments

16 . COMPANY PROFILES OF RESEARCH ANTIBODIES & REAGENTS INDUSTRY

16.1. Company Share Analysis
16.2. Market Concentration Rate
16.3. Thermo Fisher Scientific Inc. (US)
- 16.3.1. Company Overview
- 16.3.2. Company Revenue
- 16.3.3. Products
- 16.3.4. Recent Developments
16.4. Merck KGaA (Germany)
- 16.4.1. Company Overview
- 16.4.2. Company Revenue
- 16.4.3. Products
- 16.4.4. Recent Developments
16.5. Abcam plc (UK)
- 16.5.1. Company Overview
- 16.5.2. Company Revenue
- 16.5.3. Products
- 16.5.4. Recent Developments
16.6. Becton
- 16.6.1. Company Overview
- 16.6.2. Company Revenue
- 16.6.3. Products
- 16.6.4. Recent Developments
16.7. Dickinson and Company (US)
- 16.7.1. Company Overview
- 16.7.2. Company Revenue
- 16.7.3. Products
- 16.7.4. Recent Developments
16.8. Bio-Rad Laboratories (US)
- 16.8.1. Company Overview
- 16.8.2. Company Revenue
- 16.8.3. Products
- 16.8.4. Recent Developments
16.9. Cell Signaling Technology (US)
- 16.9.1. Company Overview
- 16.9.2. Company Revenue
- 16.9.3. Products
- 16.9.4. Recent Developments
16.10. F. Hoffmann-La Roche (Switzerland)
- 16.10.1. Company Overview
- 16.10.2. Company Revenue
- 16.10.3. Products
- 16.10.4. Recent Developments
16.11. Danaher Corporation (US)
- 16.11.1. Company Overview
- 16.11.2. Company Revenue
- 16.11.3. Products
- 16.11.4. Recent Developments
16.12. Agilent Technologies (US)
- 16.12.1. Company Overview
- 16.12.2. Company Revenue
- 16.12.3. Products
- 16.12.4. Recent Developments
16.13. PerkinElmer (US)
- 16.13.1. Company Overview
- 16.13.2. Company Revenue
- 16.13.3. Products
- 16.13.4. Recent Developments
16.14. Lonza (Switzerland)
- 16.14.1. Company Overview
- 16.14.2. Company Revenue
- 16.14.3. Products
- 16.14.4. Recent Developments
16.15. GenScript (China)
- 16.15.1. Company Overview
- 16.15.2. Company Revenue
- 16.15.3. Products
- 16.15.4. Recent Developments
16.16. BioLegend (US)
- 16.16.1. Company Overview
- 16.16.2. Company Revenue
- 16.16.3. Products
- 16.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies